In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

Original languageEnglish
Article number108
JournalFrontiers in Aging Neuroscience
Volume8
Number of pages10
ISSN1663-4365
DOIs
Publication statusPublished - 2016

See relations at Aarhus University Citationformats

ID: 101778362